Verve Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Verve Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q1 2024.
  • Verve Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $2.64M, a 16.1% decline year-over-year.
  • Verve Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $12.6M, a 149% increase from 2022.
  • Verve Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $5.05M, a 150% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.64M -$507K -16.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $3.15M +$2.62M +495% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $529K +$55K +11.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $474K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.